<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Importance of thrombopoietin (TPO) and its receptor (MPL) in deficient mice</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Importance of thrombopoietin (TPO) and its receptor (MPL) in deficient mice</h1>
<div class="graphic"><div class="figure"><div class="ttl">Importance of thrombopoietin (TPO) and its receptor (MPL) in deficient mice</div><div class="cntnt"><img src="data:png;base64,iVBORw0KGgoAAAANSUhEUgAAAUgAAAFHCAMAAAD0nCXUAAAACXBIWXMAAAPoAAAD6AG1e1JrAAAANlBMVEUAZjN/AAADAwPBwcEAM2aAgIAALCD/////AAB/f39DQ0MrKCiZmZlpaWng4ODw8PAATCa/AACQj/zLAAAJcElEQVR42u3dD3ujKBAG8O3MUTcz/Ln7/l/2AE3aphpBiVHzzrNdb5tsuP5WhAGFPx2iSfwBASABCUgEIAEJSEAiAAlIQCIACUhAAhIBSEACEpAIQALy/SC9NTZ0XegPHRvrvw6IckghIu06JUkHR0rkrwdEBSSHoMRMEkk5EHWW3HCI5+U7Ba++Rip5Q6aLX8kzfg2HAVLk8g4hZi1kOvfGIfswl7eoxJe1kC46ZkxHluN1MkMqIOsbG42XB0/KsYbHWs5C9noAZAUkpTCdVdIoFzXTCTocANm0Qw5IQAISkIAE5HMhY3IjgAQkqjYgAQlIQAISkIAEJCABCUhAAhK5NiABiaoNSEACEpCABCQgAQlIQCKzASQgUbUBuQ9Iz4BsAikCSEDuA9JzCt0Mkq9PA/HJIE1+hoE2hcwPjp0N0koOt2XVvlxOWLVf0f05KaSrPCPXZzYnhZTKayQgH4TDNbINpBFANrlGkla124CcvEbW9SQBie4PIPcOqXltn/seDuffuD/+XvcHkCOQRI7vO4r5gpmvnOPr/gByJLwj+nlaCg2Q6Yy8W/cHkA+ukcFGOvdtlSkeIEW4e8ZyNSdubOJpyfeQYuK56scXUALkdIR7yFzJ+W7dnwx5mYAsHbQ9IyTbIC7cf4+UA2s6I0PNuj+lg7YnhIxtiCqZkVSHfWyllavX/SlBOiEka6COpbYEQP5qZLQzgGxxjYwdnK5ywgaQm+Ta7wtpUqNiALkW0vajkRaQKyFFYm7o292yAsjieDyLiKoNyJWNzQWNDbo/+4NktNptIA1a7bWQre+PfPdW+4mQ/Hvp/t87FPDxq7ZLhpcnQhr6nA26HB8ytzPPbGwun39m4/MEkP1kTQDkasg0JMkCyPWQZAw9Mdd+G8jOfZvWAuRyyDxd6FG1G1RtZsI1cj1kuusnuKNBbvEo3s5Gf54H+exH8d4CcoucHZCAPDok2wDIJpBEJiyBLBkik3eq2mykeP7re2Zz0Y/Z0HeBZN9/LYL8+DsbH+8Cmc7FpXM2gPw6v9IDnUKAXA3Zz9kwINfn2ra6BECORbDGGAvIBsNoy6djAfktSIfHYAG5DrL2VjRATjU2imskrpG7ShG57hqJFHEi8sKHyLVRtXcDmfrjhMamzXjk0vUjAXnX2KBqt7pGGkA2uUZWDgABcqpy7z9F/D3NNjbRxq+E9LFma9g7ZMk024deXgmpaTmV3bfaJSX9/XgpZJpmKJ78ultACZDfz0hhVgfI9a32ISa/DgD5Y2VIQC6HjNdHLzgjGzQ2dniODpDrW+0LIFv0I5nRj2wx+pNabQ/I9a22R6vdbGC3AyQgDwvJSBEnYA5x6/MBII9x6/PuIY9y6/P+IQ9y6/MBqvYxbn0+AGRwwhj9adHYxIqN0Z8mw2jCaLWbDKPFqg3IBo0Nke7/brQjNDayfN2fPUOuXz4EufYNct3yIXULcfZx0qq97jarKkhatRAnIL8qANc+1QDIN8xsNoU8c2azKeSZM5ttIU+c2WwKeebMZtvGpjKzAWS7AOTU5JdbuFgxIG/hjYqJX4BsM/llULVXQgZWV5shAnI63faAbNGPxOhPk8xGyKgDZIMUkcI5cu3/VOa3IKoYMK/PtUVPAflRsAVRzR5EtddIw3SOXLukpJpHwxcsVnyOe8hfClk/1bDfzOalkPWTX4Acr6Unmo598TWS6yfQATmSa2ttWgPI0bCktRMNgBw10QVrmgJyDDIN66KxWQ15OdG9P6/tkE92f6799GHJi+8rXwCyJvKZmoYrNT3OPRwAuQQynZEhYlpywwGQiyBFuEtLS8av4bDvBZR2CinGxcoMyNWQ3bAbqvaQ+YCqXQ/JaRE/Cp0SS0x9hgMgqyHzJsdpD3PN91gNB0C+w01UgAQkIAEJSEACEpBPgcR0LCBRtQEJSEACEpCABCQgAQlIQCKzASSqNiABCUhAAvLupxtb+RGQCyHvV34E5MKqff+kNSABCcjjZTb/ksxt+SyALPjxPucf/SdU7RLIz3/m4hOQgAQkIEshH6+eD8gqyOnV8wFZVbWnV6sCJCABeRjI30nUyPppDMgWSdRt+bQDpogbQs4X9c8nIA8FefCqDUhAAhKQgAQkIAFZFMEaGwC5HlJJSAG5GjKtVCPEgFwLeSHTmbRXy3MWUHpfyOvIk+jHbGjBpHXBW9qUVFLU53WkTdpDpvXl3NcKssNaiSYWZuai4C1FsV1JXx/IzSE9KSv5DrG21bZKaoHYukMOSAQgAQlIBCBPAsnyeEMSK6HBpxS+qaCwopI2hPTXjMpR/n+3PPF62VZtw6csKqqusEclvQKSaRi7HNaQvU9Vr69z0W4l4dGm33NFVRUW6rYX3w7SDuNtU5COytJ7Xl5UVWEPS9oeUm67Iqt2t12SR17vT4DpjTZMfImHT5EfH1FaVGlh8yW9ApI5/sumfQF9rkyB8zbJI6/3J8D0znc+vhKGTxl/11xRpYXNl/TSqn27dE9UbdW1Tc18UTWF1TU1m0D21ed26XZ27PWypqZ73ADMFVVTWF1Ts10/cu7SXXYCFDUA828qKKyyqdkOkmc2ELO2xacUvqmgMK7d8AwpInJtQP7oaeR+yq2fkToez+uJpfCpd+P7dNHYs0CafvswGrYS4++3GzSPvoNuUn87Ncl5D00Np4G0gXrI+JPJUyFjB50se0MmKLFPiLa2k7NfSFWrAyQ/GbLrPz3d0RD/IxuG0gRw/5CW0q8EadJmtZtAiiPt7xDpzgMZq1voIUVstw2kivP9VmVMehpIz91Qtfsf1Rnjn161c75NJv4r8mkgh/p1g+zHsDaADK7fvQwdcnTIAYkAJCABCUgEIAEJSMShIL01lgG5OiyRTI0vMBlAlp6PeRyDufNOHHds2KVbF+PvLnSOxMTvpO/GXyI+3QWQXghOxADy5wnpBlBNkzzxS4h8/pN2Sio+j617E037kfaom4bJnALye6RHHtPoWgQ1QpzG3lz6Uz7kqh0VI93wgpAxSvFvOOMB+fMyKF0agzVp1Nf45GV6TzNAWtL+T+krQRoTK7jSho/3HaKxUXIJkkmZ3ZegxG8mZe76mUhDlvvZyPi2Tiw/d+LigJBpMJtiMxLhSK9nZH4QkvOgepobd3k2Jn8nVux80dz0OcmTdMjzM7qGXtjXPAdknhIEJFJEBCABCUhAIgAJSEACEgFIQAISAUhAAhKQCEACEpCARDSJ/wEZLKNWoRuolgAAAABJRU5ErkJggg=="/></div><div class="graphic_lgnd">Platelet counts in mice that were homozygous deficient (-/-), heterozygous deficient (+/-), or wild-type (+/+) for the thrombopoietin gene (TPO) or the thrombopoietin receptor, c-Mpl (MPL). The platelet count is 10 to 20 percent of normal in homozygous TPO or c-Mpl-deficient mice and 65 percent of normal in heterozygous TPO-deficient mice.</div><div class="graphic_reference">Data from: Gurney AL, Carver-Moore K, de Sauvage FJ, et al. Science 1994; 265:1445 and de Sauvage FJ, Carver-Moore K, Luoh SM, et al. J Exp Med 1996; 183:651.</div><div id="graphicVersion">Graphic 68869 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
